Xeris Biopharma Approves Inducement Grants for 50,000 Shares to Two New Employees

Xeris Biopharma Holdings, Inc. has disclosed the approval of inducement grants for new employees under NASDAQ Listing Rule 5635(c)(4). The company announced these grants on April 3, 2026, as part of its efforts to attract and retain talent in alignment with its growth objectives.

The inducement awards include stock options to purchase a total of 50,000 shares of Xeris common stock. These options were granted to two newly hired employees and are set to vest over four years, contingent upon continued service with the company. The grants were approved by Xeris’ Compensation Committee and issued outside the company’s existing equity incentive plans in accordance with NASDAQ’s rules governing such awards.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 3, 2026

Author

GOAI